ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

Many solid tumors including breast cancer show increased activation of several growth factor receptors, specifically EGFR and its family members (EGFRs) as well as c-Src, a non-receptor tyrosine kinase that promote proliferation, inhibit apoptosis and induce metastasis. We hypothesize that inhibitio...

詳細記述

保存先:
書誌詳細
主要な著者: Nautiyal, Jyoti, Yu, Yingjie, Aboukameel, Amro, Kanwar, Shailender, Das, Jayanta K, Du, Jianhua, Patel, Bhaumik, Sarkar, Fazlul H., Rishi, Arun K., Mohammad, Ramzi, Majumdar, Adhip P. N.
フォーマット: Artigo
言語:Inglês
出版事項: 2010
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2884079/
https://ncbi.nlm.nih.gov/pubmed/20515951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0019
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料